High prevalence of resistance to APC in young patients with retinal vein occlusion

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 240, Issue 3, 2002, Pages 163-168

  Kuhli, Claudia ^a   Hattenbach, Lars Olof ^a   Scharrer, Inge ^a   Koch, Frank ^a   Ohrloff, Christian ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTEIN C;

ACTIVATED PROTEIN C RESISTANCE; ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD CLOTTING DISORDER; CARDIOVASCULAR RISK; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; GROUPS BY AGE; HUMAN; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETINA VEIN OCCLUSION; RISK FACTOR; THROMBOPHILIA;

ACTIVATED PROTEIN C RESISTANCE; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; FLUORESCEIN ANGIOGRAPHY; FUNDUS OCULI; HUMANS; MALE; MIDDLE AGED; PREVALENCE; PROSPECTIVE STUDIES; RETINAL VEIN OCCLUSION; RISK FACTORS;

EID: 0036946590     PISSN: 0721832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00417-001-0415-1     Document Type: Article

References (31)

1. Baglivo E, Dosso A, Pournaras C (1997) Thrombus and branch retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 235:10-13
2. Bandello F, Vigano D'Angelo S, Parlavecchia M, Tavola A, Della Valle P, Brancato R, D'Angelo A (1994) Hypercoagulability and high lipoprotein(a) levels in patients with central retinal vein occlusion. Thromb Haemost 72:39-43
3. Bertina RM, Koelman BPC, Koster T, Rosendaal FR, Dirven RJ, de Ronde H, et al (1994) Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 369:64-67
4. Bertram B, Remky A, Arend O, Wolf S, Reim M (1995) Protein C, protein S, and antithrombin III in acute ocular occlusive diseases. Ger J Ophthalmol 4:332-335
5. Bloemenkamp KW, Rosendaal FR, Helmerhorst FM, Koster T, Bertina RM, Vandenbroucke JP (1998) Hemostatic effects of oral contraceptives in women who developed deep-vein thrombosis. Thromb Haemost 80:382-387
6. Ciardella AP, Yannuzi LA, Freund KB, DiMichele D, Nejat M, De Rosa JT, Daly JR, Sisco L (1998) Factor V Leiden, activated protein C resistance, and retinal vein occlusion. Retina 18:308-315
7. Dahlbäck B (1994) Physiological anti-coagulation. Inherited resistance to activated protein C and venous thromboembolism. J Clin Invest 94:923-927
8. Dahlbäck B, Carlsson M, Svensson PJ (1993) Familial thrombophilia due to a previously unrecognized mechanism characterized by poor response to activated protein C: prediction of a cofactor to activated protein C. Proc Natl Acad Sci USA 90:1004-1008
9. Gottlieb, JL, Blice JP, Mestichelli B, Konkle BA, Benson WE (1998) Activated protein C resistance, factor V Leiden, and central retinal vein occlusion in young adults. Arch Ophthalmol 116:577-579
10. Graham SL, Goldberg I, Murray B, Beaumont P, Chong BH (1996) Activated protein C resistance - low incidence in glaucomatous optic disc haemorrhage and central retinal vein occlusion. Aust N Z J Ophthalmol 24:199-205
11. Greiner K, Hafner G, Dick B, Peetz D, Prellwitz W, Pfeiffer N (1999) Retinal vascular occlusion and deficiencies in the protein C pathway. Am J Ophthalmol 128:69-74
12. Griffin JH, Evatt B, Zimmermann TS, Kleiss AJ, Wideman C (1981) Deficiency of protein C in congenital thrombotic disease. J Clin Invest 68:1370
13. Griffin JH, Evatt B, Wideman C, Fernandez JA (1993) Anticoagulant protein C pathway defective in a majority of thrombophilic patients. Blood 82:1989
14. Griffin JH, Heeb MJ, Kojima Y, Fernandez JA, Kojima K, Hackeng TM, Greengard JS (1995) Activated protein C resistance: molecular mechanisms. Thromb Haemost 74:444-448
15. Güven D, Sayinalp N, Kalayci D, Dündar S, Hasiripi H (1999) Risk factors in central retinal vein occlusion and activated protein C resistance. Eur J Ophthalmol 9:43-48
16. Hattenbach LO, Klais C, Scharrer I (1998) Heparin cofactor II deficiency in central retinal vein occlusion. Acta Ophthalmol Scand 76:758-759
17. Hattenbach LO, Beeg T, Kreuz F, Zubcov A (1999) Ophthalmic manifestation of congenital protein C deficiency. J AAPOS 3:188-190
18. Heit JA, Mohr DN, Silverstein MD, Petterson TM, O'Fallon WM, Melton LJ 3rd (2000) Predictors of recurrence after deep vein thrombosis and pulmonary embolism: a population-based cohort study. Arch Intern Med 27:761-768
19. Hellgren M, Svensson PJ, Dahlbäck B (1995) Resistance to activated protein C as a basis for venous thromboembolism associated with pregnancy and oral contraceptives. Am J Obstet Gynecol 173:210-213
20. Koster T, Rosendaal FR, de Ronde H, Briet E, Vandenbroucke JP, Bertina Rogier M (1993) Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study. Lancet 342:1503-1506
21. Larsson J, Olafsdottir E, Bauer B (1996) Activated protein C resistance in young adults with central retinal vein occlusion. Br J Ophthalmol 80:200-202
22. Larsson J, Sellman A, Bauer B (1997) Activated protein C resistance in patients with central retinal vein occlusion. Br J Ophthalmol 81:832-834
23. Larsson J, Hillarp A, Olafsdottir E, Bauer B (1999) Activated protein C resistance and anticoagulant proteins in young adults with central retinal vein occlusion. Acta Ophthalmol Scand 77:634-637
24. Makris TK, Kresoi PG, Hatzizacharias AN, Gialeraki AE, Anastasiadis G, Triposkiadis FK, Mandalaki T, Kyriakidis MK (2000) Resistance to activated protein C and FV Leiden mutation in patients with a history of acute myocardial infarction or primary hypertension. Am J Hypertens 13:61-65
25. Nelson ME, Talbot JF, Preston FE (1989) Recurrent multiple-branch retinal arteriolar occlusions in a patient with protein C deficiency. Graefes Arch Clin Exp Ophthalmol 227:443-447
26. Remky A, Arend O, Jung F, Kiesewetter H, Reim M, Wolf S (1996) Haemorheology in patients with branch retinal vein occlusion with and without risk factors. Graefe's Arch Clin Exp Ophthalmol 234 [Suppl 1]:8-12
27. Salomon O, Moisseiev J, Rosenberg N, Vidne O, Yassur I, Zivelin A, Treister G, Steinberg DM, Seligsohn U (1998) Analysis of genetic polimorphisms related to thrombosis and other risk factors in patients with retinal vein occlusion. Blood Coagul Fibrinolysis 9:617-622
28. Svensson PJ, Dahlbäck B (1994) Resistance to activated protein C as basis for venous thrombosis. N Engl J Med 330:517-522
29. The Eye Disease Case-Control Study Group (1993) Risk factors for branch retinal vein occlusion. Am J Ophthalmol 116:286-296
30. Wiek J, Krause M, Schade M, Wiederholt M, Hansen LL (1992) Haemorheological parameters in patients with retinal artery occlusion and anterior ischaemic optic neuropathy. Br J Ophthalmol 76:142-145
31. Williamson TH, Rumley A, Lowe GD (1996) Blood viscosity, coagulation, and activated protein C resistance in central retinal vein occlusion: a population controlled study. Br J Ophthalmol 80:203-208